Skip to Main Content

Paper Details

Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
Radiology
36
2021
Author NameAffiliation
Neil E FleshnerTechnical University of Munich, Germany (D.D.) Lunenfeld-Tanenbaum Research Institute, University Ave, University Health Network, Sinai Health System and University of Toronto, Princess Margaret Cancer Centre, Mount Sinai Hospital
Girish S KulkarniTechnical University of Munich, Germany (D.D.) Lunenfeld-Tanenbaum Research Institute, University Ave, University Health Network, Sinai Health System and University of Toronto, Princess Margaret Cancer Centre, Mount Sinai Hospital
Ants ToiTechnical University of Munich, Germany (D.D.) Lunenfeld-Tanenbaum Research Institute, University Ave, University Health Network, Sinai Health System and University of Toronto, Princess Margaret Cancer Centre, Mount Sinai Hospital
Theodorus H van der KwastTechnical University of Munich, Germany (D.D.) Lunenfeld-Tanenbaum Research Institute, University Ave, University Health Network, Sinai Health System and University of Toronto, Princess Margaret Cancer Centre, Mount Sinai Hospital
Alexandre R ZlottaTechnical University of Munich, Germany (D.D.) Lunenfeld-Tanenbaum Research Institute, University Ave, University Health Network, Sinai Health System and University of Toronto, Princess Margaret Cancer Centre, Mount Sinai Hospital
Antonio FinelliTechnical University of Munich, Germany (D.D.) Lunenfeld-Tanenbaum Research Institute, University Ave, University Health Network, Sinai Health System and University of Toronto, Princess Margaret Cancer Centre, Mount Sinai Hospital
Masoom A HaiderTechnical University of Munich, Germany (D.D.) Lunenfeld-Tanenbaum Research Institute, University Ave, University Health Network, Sinai Health System and University of Toronto, Princess Margaret Cancer Centre, Mount Sinai Hospital
  • 1 - 7

Datasets

Release 1.2